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Abstract
Context: The mechanisms of septic shock-associated adrenal insufficiency remain unclear. This study aimed at investigating
the synthesis of corticotropin-releasing hormone (CRH) and vasopressin (AVP) by parvocellular neurons and the
antehypophyseal expression of ACTH in human septic shock and in an experimental model of sepsis.
Objective: To test the hypothesis that ACTH secretion is decreased secondarily to alteration of CRH or AVP synthesis, we
undertook a neuropathological study of the antehypophyseal system in patients who had died from septic shock and rats
with experimental faecal peritonitis.
Methods: Brains obtained in 9 septic shock patients were compared to 10 nonseptic patients (controls). Parvocellular
expression of AVP and CRH mRNA were evaluated by in situ hybridization. Antehypophyseal expression of ACTH,
vasopressin V1b and CRH R1 receptors and parvocellular expression of iNOS in the PVN were evaluated by
immunohistochemistry. The same experiments were carried out in a fecal peritonitis-induced model of sepsis. Data from
septic rats with (n=6) or without (n=10) early death were compared to sham-operated (n=8) animals.
Results: In patients and rats, septic shock was associated with a decreased expression of ACTH, unchanged expression of
V1B receptor, CRHR1 and AVP mRNA, and increased expression of parvocellular iNOS compared to controls. Septic shock
was also characterized by an increased expression of CRH mRNA in rats but not in patients, who notably had a greater
duration of septic shock.
Conclusion: The present study suggests that in humans and in rats, septic shock is associated with decreased ACTH
synthesis that is not compensated by its two natural secretagogues, AVP and CRH. One underlying mechanism might be
increased expression of iNOS in hypothalamic parvocellular neurons.
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Introduction
About sixty percent of patients with septic shock develop
adrenal insufficiency [1] and subsequently may have higher risk of
death [2,3]. The mechanisms of impairement of the hypothalamo-
pituitary-adrenal axis (HPA) during critical illness are complex and
poorly understood and may include decreased production of
corticotropin-releasing hormone (CRH), adreno-corticotropic
hormone (ACTH) and cortisol as well as dysfunction of their
respective receptors [4]. The antehypophyseal system includes the
parvocellular neurons of the hypothalamic paraventricular nuclei
(PVN) producing CRH and vasopressin (AVP), and the ante-
hypophysis where ACTH is synthesised. CRH neurons in the
PVN project to median eminence, where CRH is released into the
hypophyseal portal circulation to stimulate ACTH secretion via
essentially CRH receptor 1 (CRHR1), which is the most abundant
form of CRH receptors [5,6]. AVP produced by the parvocellular
neurons also controls ACTH secretion via V1b receptor [7].
Most human studies of HPA axis during sepsis have relied on
circulating hormonal levels and have never included neuropath-
ological studies. Previous experimental studies investigated hy-
pothalamo-pituitary structures and showed that endotoxin or
cytokines stimulate CRH neurons [8]. However, they rarely
assessed concomitantly the expression of AVP and CRH and their
respective receptors as well as relationships between HPA
activation and the severity of sepsis.
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secondarily to alteration of either CRH or AVP synthesis, we
underwent a neuropathological study of the antehypophyseal
system in patients who had died from septic shock and rats with
experimental faecal peritonitis, which is considered one of the best
model of human sepsis [9]. Faecal peritonitis enables to obtain
various degree of sepsis severity [10,11] and seems an appropriate
model for assessing pathophysiological mechanisms of sepsis-
induced hormonal disturbances [12,13].
Methods
In Vivo Model of Fecal Peritonitis
Experiments were carried out at University College London,
with Home Office approval in accordance with the Animal
Scientific Procedures Act (European Community’s Council
Directive (24/11/1986; 86/609/EEC). Wistar rats were pur-
chased from Charles River laboratory (Arbresle, France). This
model has been well described elsewhere [11]. Briefly, anesthetised
male Wistar rats were instrumented to develop sepsis by
intraperitoneal injection of fecal slurry (0.63 mg/100 g body
weight) prepared from the bowel contents of a rat from the same
batch. Fluid resuscitated rats were randomly divided as follows: 1)
sham-operated controls that received no intraperitoneal injection
but were otherwise treated identically; 2) Rats that underwent
experimental peritonitis and were classified as severe sepsis if they
did not die spontaneously (i.e. septic rats) and as septic shock if
they died spontaneously (i.e. septic early death (ED) rats). Sham
and septic rats were killed by cervical dislocation at 24 or 48 hours
after injection of slurry. All septic shock rats died within 36 hours.
All septic and septic ED animals showed features of illness from
about 12 h after injection of fecal slurry, including hunched
posture, piloerection, and decreased movement and alertness. At
24 hours, there was a significant decrease in mean arterial pressure
in septic rats (11562 mmHg controls, 10664 mmHg septic,
p,0.05). In all septic and septic shock rats, laparotomy showed
evidence of peritoneal inflammation.
Brain sampling was performed in eight sham, ten septic and six
septic shock rats. Whole brains and pituitary glands were removed
immediately after animal sacrifice by neck dislocation, and fixed
by immersion in 10% formalin. Brain samples were processed as
previously described [14]. Briefly, after embedding in paraffin,
serial sections of 4 mm were performed (LeicaH microtome) until
the region of interest was reached. Coronal sections of the PVN
nuclei and horizontal sections of the pituitary gland were then
stained with haematoxylin and eosin before microscopic exami-
nation or treated for immunohistochemistry or in situ hybridiza-
tion.
Patients
Nine non-survivors from septic shock and ten non-septic
patients who died from cardiogenic shock or an extracranial
cause of sudden death were included. The characteristics of these
patients have been reported elsewhere (10). The median age of
patients who died from septic shock was 71 [58–76] years. Their
SAPS-II score was 57 [35–90], the cumulative time of hypotension
was 25 [12–36] h and duration of shock 6 [1–8] days. In patients
who died from non-septic causes, SAPS-II score was higher (i.e. 70
[47–83]) but cumulative time of hypotension and duration of
shock were shorter, namely 3 [2–5] h and 3 [1–4] days,
respectively.
Macroscopic examination of the brains was performed after 4 to
6 weeks of fixation in 10% formalin (vol./vol.). We took samples of
the PVN at the level of the posterior hypothalamus. Pituitary
glands were also sampled. Each sample was embedded in paraffin
and cut in 4 mm serial sections with a LeicaH microtome. For
microscopic examination, one section on three was stained with
haematoxylin and eosin; the others were processed for immuno-
histochemistry or in situ hybridization.
Human ethics
According to national regulations, brain samples were collected
after obtaining informed written consent from patient’s closest
relatives. A protocol about sampling for research purpose by title
Anatomopathological study of neuroendocrine and neurovegetative trouble during
septic shock (nuPFS10-008) was approved by the French Biomede-
cine Agency.
Moreover, patients of our work from Raymond Poincare ´
Hospital (Garches) were enrolled in the CORTICUS study [15].
Written informed consent was provided from a surrogate, the next
of kin, or a legal representative (with retrospective consent
obtained from patients who regained competency) if lacked
mental competency. CORTICUS provided an anatomopatholo-
gical study and was approved by the Comite ´ Consultatif de
Protection des Personnes se Pre ˆtant a ` la Recherche Biome ´dicale
de Saint Germain en Laye, France.
Immunohistochemistry (IHC)
Immunohistochemistry was performed on deparaffinised for-
malin-fixed sections using an indirect ABC-peroxidase method
revealed with 3-39diaminobenzidine (DAB) or amino-ethyl-
carbazol (AEC) as chromogenes [14]. For homogeneity of
labelling, immunohistochemistry was performed using an auto-
mated IHC slide-staining system (NexESH IHC Full system,
Ventana Medical Systems, Tucson, AZ, USA). Primary antibodies
and species specificities are summarized in table 1. Sections were
incubated for 30 min with primary antibodies. Slides were then
counterstained with bluing reagent for 4 minutes and mounted in
EukittH for microscopic evaluation. Omission of the primary
antibodies and replacement by isotype-matched irrelevant anti-
body was used for negative control.
Images were acquired using a Leitz DiaplanH microscope
(Solms, Germany) equipped with a Nikon Coolpix 950H digital
camera (Champigny sur Marne, France).
In situ hybridization
In situ hybridization was performed using a 200 bp rat
vasopressin cDNA probe (gift from Dr C Rabadan-Diehl,
Bethesda, MD, USA) and 1 kb rat CRH cDNA probe (gift from
Dr Mayo, Evanston, IL, USA) as described previously [14].
Briefly, sense and antisense probes were synthesized from
linearized plasmids using digoxigenin-UTP (Roche, France) and
riboprobe combination system (Promega, France). In situ hybrid-
ization was performed using the Ventana DiscoveryH (Ventana
Medical Systems, Tucson, AZ, USA). Slides were finally mounted
with Vectashield mounting medium (Vector Labs-AbCys, Paris,
France). The labelled cells were observed with an Axioplan 2
microscope (Zeiss, Go ¨ttingen, Germany) equipped with a video
camera (Micromax 1MHz, Kodak chip). Images were acquired
with AxioVision acquisition and analysis software. Sections
hybridized with sense probes showed no staining.
Evaluation of immunostaining and in situ hybridization
Immunostaining and in situ hybridization were assessed by two
independent observers (AP, RS), blind to rats and patients’ groups.
Counting of parvocellular neurones was performed morphomet-
rically using Image J 1.36bH software (Wayne Rasband, National
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were performed on one 4 mm-treated slice containing the PVN (at
the level 21.4 or 21.8 mm from Bregma, according to the
stereotaxic rat brain atlas of Paxinos and Watson, 1997 [16]). For
humans, one slice representative of PVN was selected for counting.
The intensity of CRH (in-situ hybridization), AVP (in-situ
hybridization) and iNOS (immunohistochemistry) labelling of
each neuron was semi-quantitatively scored as 0 (none), 1 (low), 2
(moderate) or 3 (high) in the PVN (Fig. 1 A, B). To take into
account both the amount of positive neurones and the cellular
intensity of immunostaining, the following index was then
calculated for each nucleus: (1*number (n) of low intensity cells +
2*n of moderate intensity cells +3*n of high intensity cells)/(total n of positive
and negative neurons) [14,17]. Therefore, this index ranged from 0 to
3. This index was developed using the hypothalamic nuclei of
naı ¨ve rats and from patients who did not die from septic shock
(Figure 1).
In the antehypophysis of each rat or patient, stores of ACTH,
AVP, V1B receptor and CRH1 receptor were scored with a semi-
quantitative scale, ranging from 0 to 3 (pourquoi cette e ´chelle ne
va pas de 0 a ` 3 ??), depending on the global immunostaining
intensity at the level of the section considered.
Statistical analysis
Variables were expressed as median with interquartile ranges (25
th–
75
th percentile), respectively. Non parametric analyses were per-
formed, using Kruskall-Wallis and Mann-Whitney test for comparison
of quantitative variables between three and two groups, respectively.
To account for multiplicity while testing the same physiological
hypothesis in humans and rats, p-vlaues were adjusted using Holm’s
correction. A p-value less than 0.05 was deemed significant.
Results
Expression of CRH, AVP and iNOS in the parvocellular
nuclei
In patients, parvocellular expression of CRH mRNA did not
differ statistically between septic shock and controls (p=0.65)
(Table 2 and Figure 1).
By contrast, in rats the parvocellular expression of CRH mRNA
differed significantly between groups (p=0.04), and was higher in
septic shock than in sham (p=0.02) and tended to be higher than
septic animals (p=0.08) (Table 2 and Figure 2). It did not differ
between sham and septic rats (p=0.21).
In patients, parvocellular expression of AVP mRNA did not
differ statistically between septic shock and controls (p=1.00)
(Table 2 and Figure 1). Similarly, in rats parvocellular expression
of AVP mRNA did not differ between septic and non-septic
animals (p=1.00) (Table 2 and Figure 2).
In patients, the index of parvocellular neurons immunoreactive
for iNOS was significantly higher in septic shock than in controls
(p=0.0008) (Table 2 and Figure 1). Similarly, in rats, the index of
parvocellular neurons immunoreactive for iNOS differed signifi-
cantly between groups (p=0.007) (Table 2 and Figure 2). It was
significantly higher in septic shock than in septic (p=0.01) animals
and sham (p=0.01) animals. It was not significantly different
between septic and sham rats (p=0.43).
In parvocellular nuclei expression of CRH mRNA, AVP
mRNA and iNOS in patients did not correlate with duration of
septic shock. Evaluation of steroid effect was not possible because
of the small number of patients treated.
Expression of CRHR1, V1b and ACTH in the
ante-hypophysis
In patients, the antehypophyseal expression of ACTH was
significantly lower in septic shock than in controls (p=0.04)
Table 1. Antibodies.
Antibody Manufacturer Reference Specificity*
AVP ChemiconH international, CA, USA AB1565 H, R
ACTH ChemiconH international, CA, USA CBL56 H, R
iNOS USBiological, MA, USA I7570-31 H, R
V1b R ALPHA DIAGNOSTIC, TX, USA AVP1B13-5 H, R
CRHR1 Acris antibodies GmbH HERFORD, GERMANY SP4643P H, R
*H: human; R: rat.
doi:10.1371/journal.pone.0025905.t001
Figure 1. PVN of patients who died from non-septic causes (A–
C–E) or septic shock (B–D–F). CRH mRNA (A–B) and AVP mRNA (C–
D) labelling after in situ hybridization expression did not differ between
the two groups. iNOS (E–F) expression after immunohistochemistry
(ABC peroxidase/DAB) was higher in septic shock patients.
doi:10.1371/journal.pone.0025905.g001
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septic ED rats.
Humans Rats
Controls Septic Shock p Sham Septic Septic ED p
CRH mRNA 1.8[1.5–2.0] Fig. 1A 1.8[1.7–1.8] Fig. 1B 0.65 1.6[1.6–1.7] Fig. 2A 1.8[1.6–1.8] Fig. 2B
b2.0[1.9–2.0] Fig. 2C 0.04
AVP mRNA 1.3[1.3–1.4] Fig. 1C 1.4[1.3–1.5] Fig. 1D 1.00 2.1[2.0–2.3] Fig. 2D 2.3[2.0–2.3] Fig. 2E 2.1[1.9–2.3] Fig. 2F 1.00
iNOS 0.0[0.0–0.0] Fig. 1E 1.0[1.0–1.0] Fig. 1F 0.0008 0.0[0.0–2.0] Fig. 2G
a1.0[1. –1.3] Fig. 2H
b3.0[2.3–3.0] Fig. 2I 0.007
Abbreviations: AVP, Vasopressin; CRH, Corticotropin Releasing Hormone; mRNA, messenger RNA; iNOS, inducible nitric oxide synthase; ED, Early death.
Results are expressed as median (IQR).The index of labelling CRH and AVP in-situ hybridization and iNOS immunohistochemistry ranged from 0 to 3.
Comparison between the following animal groups:
aSham versus Sepsis,
bSepsis versus Septic Shock,
cSham versus Septic Shock.
doi:10.1371/journal.pone.0025905.t002
Figure 2. PVN of sham (A–D–G), septic (B–E–H) and septic with early death (septic ED) (C–F–I) rats. Expression of CRH mRNA (A–B–C) and
iNOS (G–H–I) after immunohistochemistry (ABC peroxidase/DAB) was greater in septic ED rats. AVP mRNA (D–E–F) expression after in situ
hybridization did not differ between the three groups.
doi:10.1371/journal.pone.0025905.g002
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expression of ACTH varied significantly among groups (p=0.002)
(Table 3 and Figure 4). It was lower in septic shock than in either
sham (p=0.0004) or sepsis (p=0.01) (Table 3 and Figure 3). It did
not differ between sham and septic rats (p=0.19) (Table 3 and
Figure 4).
In patients and in rats, expression of CRHR1 did not differ
between groups (p=0.66 and p=0.71, respectively). It was the
same for V1b receptor (p=0.44 for both), as shown in table 3 and
figures 3 and 4.
In ante-hypophysis expression of CRH R1, V1b and ACTH in
patients did not correlate with duration of septic shock. The small
number of patients treated with steroids preclude to assess their
effect.
Discussion
This study assessed sepsis-induced ACTH expression and
expression of its main regulators, both in patients and in rats.
Decreased ACTH and unchanged expression of AVP mRNA,
CRHR1, and V1b receptors was a consistent finding in human
and in rats. Conversely, CRH mRNA expression was increased in
rats with septic shock but not in patients with septic shock. These
results suggest that septic shock is associated with central
impairment of the HPA, characterized by decreased ACTH
synthesis while its two main regulators CRH and AVP remain
roughly unchanged.
Exposure toan acute stressful stimulus is followed by rapid and self-
limited increase in plasmatic ACTH and corticosterone [18,19].
However, if the stimulus is repeated, plasma glucocorticoid levels are
usually above basal values but plasma ACTH responses vary, being
preserved or desensitized according to the nature of the stimulus
[20,21,22,23,24]. Similarly to our study, in a cecal ligation and
puncture (CLP)model,Carlson and colleagues showed an increase of
CRH expression in PVN [25] and a reduced adrenocortical
sensitivity to ACTH during acute and post-acute phase [26] as well
as Oliveira-Pelegrin and colleagues showed no change in the
paraventricular AVP expression between CLP and sham rats [27].
It has been shown that LPS down-regulates the mRNA coding for
AVP and CRH antehypophyseal receptors; however,the effect of
prolonged experimental sepsis on these receptors has not been
assessed yet. Given that these conclusions are comparable with our
findings, we think that the originality of our work lies on a broad
d e s c ri p t i o no ft h eHP Ab o t hi nh u ma na n da n i m a ls ,i np o s t - a c u t ea n d
ultimate phase of septic shock. Additionally, one may argue that
variation of variable value is low. This is due to the large interval of
the scores that we used, which enabled to detect clear and obvious
rather than subtle and disputable difference. It reflects also the
reproducibility between evaluators and the standardization of brain
sampling and experimental models.
Our results show that HPA axis appeared non-reactive. It seems
unlikely that sepsis induced by the surgical model was not enough
severe to activate HPA axis. Faecal peritonitis constitutes a
sustained stimulus sufficient to induce tissue inflammation and
impairment of visceral sensory pathways [28,29,30]. It has been
previously showed that CLP reflects the clinical course of sepsis
[9,31] and all our septic animals showed features of severe illness.
Moreover, this surgical model has been used to assess central
Table 3. Antehypophyseal expression of ACTH, CRHR1 and V1b receptor in control and septic shock patients and in sham, septic
and septic ED rats.
Humans Rats
Controls Septic Shock p Sham Septic Septic ED p
CRHR1 3.0[2.3–3.0] Fig. 3A 2.0[2.0–3.0] Fig. 3B 0.66 3.0[2.0–3.0] Fig. 4A 2.5[1.2–3.0] Fig. 4B 2.0[2.0–2.0] Fig. 4C 0.71
V1b 2.0[1.3–2.8] Fig. 3C 1.8[1.1–2.0] Fig. 3D 0.44 2.0[2.0–2.0] Fig. 4D 2.0[2.0–2.0] Fig. 4E 2.0[2.0–2.0] Fig. 4F 0.44
ACTH 3.0[3.0–3.0] Fig. 3E 2.0[1.6–2.0] Fig. 3F 0.04 2.0[2.0–2.0] Fig. 4G
a2.0[1.5–2.0] Fig. 4H
b1.0[1.0–1.0] Fig. 4I 0.002
Abbreviations: ACTH, Adreno-Corticotropic Hormone; V1b, Vasopressin receptor 1b; CRHR1, Corticotropin Releasing Hormone receptor 1; ED, Early death.
Results are expressed as median (IQR). The index of labelling of ACTH, CRHR1 and V1b receptor immunohistochemistry ranged from 0 to 3.
Comparison between the following animal groups:
aSham versus Sepsis,
bSepsis versus Septic Shock,
cSham versus Septic Shock.
doi:10.1371/journal.pone.0025905.t003
Figure 3. Ante-hypophysis of patients who died from non-
septic causes (A–C–E) or septic shock (B–D–F). Labelling of CRHR1
(A–B) and V1b receptor (C–D) after immunohistochemistry (ABC peroxi-
dase/DAB) did not vary among the two groups. ACTH (E–F) immunostain-
ing (ABC peroxidase/DAB) was decreased in septic shock patients.
doi:10.1371/journal.pone.0025905.g003
CRH and ACTH Synthesis in Sepsis
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septic patients.
Our study provides just a snapshot of the HPA axis’s state at a
given time of course of sepsis. Septic and septic shock animals were
sacrificed or spontaneously died within 36 hours and patients died
after several days of septic shock complicated by multiple organ
failure. Thus, our description of HPA axis rather corresponds to
the post-acute phase of sepsis in the experimental model, while
that in septic patients to the ultimate phase. This difference may
explain the finding that expression of CRH was greater in rats
than in humans. Interestingly, a previous experimental study
showed that parvocellular CRH expression peaked 24 hours after
onset of CLP [25], suggesting that animals died in the post-acute
phase of septic shock. To our knowledge there is no study that
correlates neuropathological findings in HPA axis with the severity
of the septic shock. It was not possible to determine whether the
absence of increase in CRH depends on septic shock duration,
intensity or both since all patients died from severe septic shock.
The finding that CRH expression did not vary among patients
according to the duration of septic shock (data not shown) supports
that sepsis intensity was a determinant factor.
Another hypothesis to explain our results is based on the
regulatory role of endogenous and exogenous glucocorticosteroids
on HPA during stress. Indeed, cortisol exerts a negative feedback
on PVN, reducing CRH and AVP mediated ACTH secretion
[32].
Carlson and colleagues showed that plasma cortisol level
decreased with time in CLP [26]. It is likely that similar kinetics
took place in rats with faecal peritonitis, although we were not able
to measure plasma cortisol level. Because of this decrease, it is
unlikely then that endogenous glucocorticoids account for
neuropathological findings in septic rats, notably decreased ACTH
expression. None of the rats were treated with steroids. As plasma
cortisol levels were not available in patients, we are not able to
assess whether it correlated with CRH, AVP and ACTH secretion.
One may argue that patient who had died from septic shock would
have had increased plasma cortisol level. This is controversial. If
increased plasma cortisol level at onset of septic shock, was
associated with mortality [1], few studies have assessed whether
this relationship remain along the course of septi shock. It has been
reported that plasma cortisol level [33] or free cortisol level [34]
decreased with time. It has been shown no difference in the
decrease with time of free cortisol level [34] or in plasma cortisol
levels before and during low–dose hydrocortisone therapy [35]
between survivors between survivors and non survivors from
multitrauma, sepsis [34] or septic shock [35]. We recently reported
that plasma cortisol levels after 10 days in average from admission
were higher in patients who will die than survive from severe
critical illness [36]. It is therefore difficult to figure the
relationships between plasma cortisol level and mortality along
the course of the septic shock, the hypotheses that death is
associated with high or low levels being both plausible,. Once
again, small number of patients treated with steroids precludes to
asssess their correlation with neuropathological findings.
The role of iNOS on neuroendocrine modulation of axis is well
recognized and his expression may contribute to stunting of HPA
in sepsis. Most experimental studies reported that nitric oxide
stimulates the expression of CRH [37] and suppresses the
Figure 4. Ante-hypophysis of sham (A–D–G), septic (B–E–H) and septic with early death (septic ED) (C–F–I) rats. Labelling of CRHR1 (A–
B–C) and V1b receptor (D–E–F) after immunohistochemistry (ABC peroxidase/DAB) did not vary among the three groups. ACTH (G–H–I)
immunostaining (ABC peroxidase/DAB) was decreased in septic ED.
doi:10.1371/journal.pone.0025905.g004
CRH and ACTH Synthesis in Sepsis
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an inhibitory action on AVP synthesis both in magnocellular [14]
and parvocellular cells during sepsis [40]. The pro-apoptotic
action of iNOS in PVN may also partially account for the reduced
reactivity of HPA in sustained septic shock [41]. It would be
interesting in a future experimental study to assess to what extent
iNOS inhibition modifies the ante-hypophyseal system in septic
and septic ED rats. We acknowledge that the present study is
mainly descriptive and that we are not able to determine whether
the observed phenomena were the cause of death. But we
reasoned that before proposing experimental intervention (such as
iNOS inhibition) a thorough description of ante-hypophyseal
system was necessary.
In conclusion, the present study suggests that in humans and in
rats, septic shock is associated with decreased ACTH synthesis that
is not compensated by its two natural secretagogues AVP and
CRH. One underlying mechanism might be increased expression
of iNOS.
Further studies are necessary to assess other mechanisms and to
elucidate the role of HPA impairment on relative adrenal failure in
sepsis.
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